News
News
Male Infertility Symposium – Landmark…
The Jordanian Society for Fertility and Genetics recently hosted a scientific symposium…
Prolistem® at the ESHRE 41th…
We are proud to have participated in the 41st Annual ESHRE Conference…
NEW STUDY: ENHANCING MICROTESE SUCCESS,…
OBJECTIVE To evaluate the efficacy of Prolistem, a novel supplement, in enhancing…
Prolistem® at the ESHRE 40th…
We are honored to participate in the highly anticipated ESHRE 2024 Conference,…
Prolistem® at the ASRM– Denver…
We are honored to participate in the prestigious ASRM 2024 Conference in…
Prolistem® Joins the ASRM 2024…
Prolistem® Joins the ASRM 2024 Conference in Denver We are thrilled to…
Prolistem® Clinical Approved by the…
The Prolistem treatment has emerged as a breakthrough for men grappling with…
Prolistem® approved by JFDA
We are thrilled to announce that Prolistem®, developed by Medhija LLC, has…